| Issuer | % of Class | Filed |
|---|---|---|
|
Liminatus Pharma, Inc.
13G/A
Amendment 1
LIMN · 53271X108
|
10.9% |
7/6/2026
Event 6/24/2026
|
|
Liminatus Pharma, Inc.
13G
LIMN · 53271X108
|
5.8% |
6/26/2025
Event 4/30/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.